| For: | Lytvyak E, Montano-Loza AJ, Mason AL. Combination antiretroviral studies for patients with primary biliary cirrhosis. World J Gastroenterol 2016; 22(1): 349-360 [PMID: 26755881 DOI: 10.3748/wjg.v22.i1.349] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/349.htm |
| Number | Citing Articles |
| 1 |
Mariam Goubran, Weiwei Wang, Stanislav Indik, Alexander Faschinger, Shawn T. Wasilenko, Jasper Bintner, Eric J. Carpenter, Guangzhi Zhang, Paulo Nuin, Georgina Macintyre, Gane K.-S. Wong, Andrew L. Mason. Isolation of a Human Betaretrovirus from Patients with Primary Biliary Cholangitis. Viruses 2022; 14(5) doi: 10.3390/v14050886
|
| 2 |
Dongwei Guo, Tian Zhou, Mariluz Araínga, Diana Palandri, Nagsen Gautam, Tatiana Bronich, Yazen Alnouti, JoEllyn McMillan, Benson Edagwa, Howard E. Gendelman. Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine. JAIDS Journal of Acquired Immune Deficiency Syndromes 2017; 74(3) doi: 10.1097/QAI.0000000000001170
|
| 3 |
Francesca Saffioti, Kurinchi Selvan Gurusamy, Leonardo Henry Eusebi, Emmanuel Tsochatzis, Brian R Davidson, Douglas Thorburn. Pharmacological interventions for primary biliary cholangitis. Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD011648.pub2
|
| 4 |
David Chascsa, Elizabeth J. Carey, Keith D. Lindor. Old and new treatments for primary biliary cholangitis. Liver International 2017; 37(4) doi: 10.1111/liv.13294
|
| 5 |
Victor Dong, Aldo J. Montano-Loza, Andrew L. Mason. Modelling Recurrent Primary Biliary Cholangitis and Primary Sclerosing Cholangitis as Infectious Diseases Following Liver Transplantation. OBM Transplantation 2019; 3(04) doi: 10.21926/obm.transplant.1904094
|
| 6 |
Maren H. Harms, Henk R. van Buuren, Adriaan J. van der Meer. Improving prognosis in primary biliary cholangitis – Therapeutic options and strategy. Best Practice & Research Clinical Gastroenterology 2018; doi: 10.1016/j.bpg.2018.06.004
|
| 7 |
Guangzhi Zhang, Kiandokht Bashiri, Mark Kneteman, Kevan Cave, Youngkee Hong, John R. Mackey, Harvey J. Alter, Andrew L. Mason. Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease. Journal of Oncology 2020; 2020 doi: 10.1155/2020/8958192
|
| 8 |
Eirini I. Rigopoulou, Andreas L. Koutsoumpas, Dimitrios P. Bogdanos. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. 2022; doi: 10.1007/978-981-19-1946-6_6
|
| 9 |
Liu-Hong Shen, Lei Fan, Yue Zhang, Ying-Kun Zhu, Xiao-Lan Zong, Guang-Neng Peng, Sui-Zhong Cao. Protective Effect and Mechanism of Placenta Extract on Liver. Nutrients 2022; 14(23) doi: 10.3390/nu14235071
|
| 10 |
Vincenzo Ronca, Marco Carbone, Francesca Bernuzzi, Federica Malinverno, Hani S. Mousa, M. Eric Gershwin, Pietro Invernizzi. From pathogenesis to novel therapies in the treatment of primary biliary cholangitis. Expert Review of Clinical Immunology 2017; 13(12) doi: 10.1080/1744666X.2017.1391093
|
| 11 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, John M. Vierling, David Adams, Gianfranco Alpini, Jesus M. Banales, Ulrich Beuers, Einar Björnsson, Christopher Bowlus, Marco Carbone, Olivier Chazouillères, George Dalekos, Andrea De Gottardi, Kenichi Harada, Gideon Hirschfield, Pietro Invernizzi, David Jones, Edward Krawitt, Antonio Lanzavecchia, Zhe-Xiong Lian, Xiong Ma, Michael Manns, Domenico Mavilio, Eamon MM. Quigley, Federica Sallusto, Shinji Shimoda, Mario Strazzabosco, Mark Swain, Atsushi Tanaka, Michael Trauner, Koichi Tsuneyama, Ehud Zigmond, M. Eric Gershwin. The challenges of primary biliary cholangitis: What is new and what needs to be done. Journal of Autoimmunity 2019; 105 doi: 10.1016/j.jaut.2019.102328
|
| 12 |
Jeremy Liu Chen Kiow, Catherine Vincent, Sacha Sidani, Mickael Bouin. High occurrence of small intestinal bacterial overgrowth in primary biliary cholangitis. Neurogastroenterology & Motility 2019; 31(11) doi: 10.1111/nmo.13691
|
| 13 |
Shannon Turvey, Lynora Saxinger, Andrew Mason. Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis. Viruses 2022; 14(3) doi: 10.3390/v14030516
|
| 14 |
Ellina Lytvyak, Mina Niazi, Rohit Pai, Daniel He, Guangzhi Zhang, Stefan G. Hübscher, Andrew L. Mason. Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation. Liver International 2021; 41(8) doi: 10.1111/liv.14964
|
| 15 |
Andrew L. Mason. Is PBC a viral infectious disease?. Best Practice & Research Clinical Gastroenterology 2018; doi: 10.1016/j.bpg.2018.06.001
|
| 16 |
Albert J. Czaja. Clinical Epidemiology of Chronic Liver Diseases. 2019; doi: 10.1007/978-3-319-94355-8_16
|